These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26515411)

  • 21. Gender differences in pain and patient reported outcomes: a secondary analysis of the NCIC CTG SC. 23 randomized trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S185-S194. PubMed ID: 29156903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD; Crook JM; Lukka H
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.
    Kaasa S; Brenne E; Lund JA; Fayers P; Falkmer U; Holmberg M; Lagerlund M; Bruland O
    Radiother Oncol; 2006 Jun; 79(3):278-84. PubMed ID: 16793154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prediction model of survival for patients with bone metastasis from uterine cervical cancer.
    Matsumiya H; Todo Y; Okamoto K; Takeshita S; Yamazaki H; Yamashiro K; Kato H
    J Gynecol Oncol; 2016 Nov; 27(6):e55. PubMed ID: 27550401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing Discontinuation of Radiation Therapy: Predictive Factors to Improve Patient Selection for Palliative Treatment.
    Puckett LL; Luitweiler E; Potters L; Teckie S
    J Oncol Pract; 2017 Sep; 13(9):e782-e791. PubMed ID: 28759295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases.
    Hamouda WE; Roshdy W; Teema M
    Gulf J Oncolog; 2007 Jan; 1(1):35-41. PubMed ID: 20084712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for psychological distress before radiotherapy for painful bone metastases may be useful to identify patients with high levels of distress.
    Westhoff PG; de Graeff A; Monninkhof EM; Berveling MJ; van Vulpen M; Leer JWH; Marijnen CAM; Reyners AKL; van der Linden YM;
    Acta Oncol; 2017 Dec; 56(12):1720-1727. PubMed ID: 28893119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy.
    van der Linden YM; Dijkstra SP; Vonk EJ; Marijnen CA; Leer JW;
    Cancer; 2005 Jan; 103(2):320-8. PubMed ID: 15593360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of care and survival outcomes of palliative radiation for prostate cancer with bone metastases: comparison of ≤5 fractions to ≥10 fractions.
    Schreiber D; Safdieh J; Becker DJ; Schwartz D
    Ann Palliat Med; 2017 Jan; 6(1):55-65. PubMed ID: 28209069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
    Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
    PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiotherapy of bone metastases in France: A descriptive monocentric retrospective study].
    Le Fèvre C; Antoni D; Thiéry A; Keller A; Truntzer P; Vigneron C; Clavier JB; Guihard S; Pop M; Schumacher C; Salze P; Noël G
    Cancer Radiother; 2018 Apr; 22(2):148-162. PubMed ID: 29602695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.
    Radiother Oncol; 1999 Aug; 52(2):111-21. PubMed ID: 10577696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy.
    Valeriani M; Scaringi C; Blasi L; Carnevale A; De Sanctis V; Bonome P; Bracci S; Marrone G; Minniti G; Enrici RM
    Tumori; 2015; 101(3):318-22. PubMed ID: 25908049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Optimal doses and timing for tele-irradiation of bone metastases in patients with life expectancy more than 3 months].
    Khmelevskiĭ EV; Pan'shin GA; Dobrovol'skaia NIu; Bol'shakova SA
    Vopr Onkol; 2012; 58(3):380-6. PubMed ID: 22888655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy for painful bone metastases from hepatocellular carcinoma.
    Seong J; Koom WS; Park HC
    Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U).
    Chow E; DeAngelis C; Chen BE; Azad A; Meyer RM; Wilson C; Kerba M; Bezjak A; Wilson P; Nabid A; Greenland J; Rees G; Vieth R; Wong RK; Hoskin P
    Radiother Oncol; 2015 Apr; 115(1):141-8. PubMed ID: 25782738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial.
    Chow S; Ding K; Wan BA; Brundage M; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Chow E
    Am J Hosp Palliat Care; 2018 Apr; 35(4):718-723. PubMed ID: 28950727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.